NBIX Neurocrine Biosciences
$150.57 -3.84%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-3.84%
YTD
+6.20%
P/E
22.18
P/B
4.35
ROE
19.7%
Div yield
—
Beta
0.74
Market cap
$15.6B
RSI (14)
43
Next earnings
Feb 9, 2027
Same sector · Health Care
Compare NBIX with NVO and JNJ →Follow NBIX in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$156.27
Close
$150.57
Day high
$158.26
Day low
$150.24
Volume
1.6M
Latest headlines
Neurocrine Biosciences (NBIX) Stock Still Looks Undervalued As Its 89% Run Draws Focus
Yahoo Finance · Nov 18
Should You Buy Neurocrine Biosciences Stock For Its Cash?
Yahoo Finance · Nov 16
Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
Yahoo Finance · Nov 10
NBIX or GRDN: Which Is the Better Value Stock Right Now?
Yahoo Finance · Nov 10
Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice
Yahoo Finance · Nov 9
All You Need to Know About Neurocrine (NBIX) Rating Upgrade to Buy
Yahoo Finance · Nov 9
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Nov 2, 2026 View → 8-K Nov 2, 2026 View → 8-K Sep 28, 2026 View → 10-Q Jul 31, 2026 View → 8-K Jul 30, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell NBIX. Try it in the Lab to size a position and see the risk.